Drug industry executives don’t get it: They’re not supposed to be the bad guys.
That was the feeling that seemed to permeate the annual meeting of the Pharmaceutical Research and Manufacturers of America, which gathered here this week amid withering scrutiny from politicians and the public.
Read Full Article »